143 related articles for article (PubMed ID: 12096293)
1. Patients' perceptions of fatigue in response to biochemotherapy for metastatic melanoma: a preliminary study.
Fu MR; Anderson CM; McDaniel R; Armer J
Oncol Nurs Forum; 2002 Jul; 29(6):961-6. PubMed ID: 12096293
[TBL] [Abstract][Full Text] [Related]
2. Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.
Kim KB; Eton O; East MJ; Hodges C; Papadopoulos NE; Grimm EA; Bedikian AY
Cancer; 2004 Aug; 101(3):596-603. PubMed ID: 15274073
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness of nursing education as an intervention to decrease fatigue in Turkish patients receiving chemotherapy.
Yesilbalkan OU; Karadakovan A; Göker E
Oncol Nurs Forum; 2009 Jul; 36(4):E215-22. PubMed ID: 19581225
[TBL] [Abstract][Full Text] [Related]
4. Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate.
Schwartz AL; Thompson JA; Masood N
Oncol Nurs Forum; 2002 Aug; 29(7):E85-90. PubMed ID: 12183762
[TBL] [Abstract][Full Text] [Related]
5. The trajectory of fatigue in adult patients with breast and ovarian cancer receiving chemotherapy.
Payne JK
Oncol Nurs Forum; 2002 Oct; 29(9):1334-40. PubMed ID: 12370703
[TBL] [Abstract][Full Text] [Related]
6. Biochemotherapy in patients with advanced head and neck mucosal melanoma.
Bartell HL; Bedikian AY; Papadopoulos NE; Dett TK; Ballo MT; Myers JN; Hwu P; Kim KB
Head Neck; 2008 Dec; 30(12):1592-8. PubMed ID: 18798304
[TBL] [Abstract][Full Text] [Related]
7. Basal level and behaviour of cytokines in a randomized outpatient trial comparing chemotherapy and biochemotherapy in metastatic melanoma.
Guida M; Riccobon A; Biasco G; Ravaioli A; Casamassima A; Freschi A; Palma MD; Galligioni E; Nortilli R; Chiarion-Sileni V; Picozzo J; Romanini A; Nanni O; Ridolfi R;
Melanoma Res; 2006 Aug; 16(4):317-23. PubMed ID: 16845327
[TBL] [Abstract][Full Text] [Related]
8. Just go with the flow: a qualitative study of fatigue in biotherapy.
Porock D; Juenger JA
Eur J Cancer Care (Engl); 2004 Sep; 13(4):356-61. PubMed ID: 15305904
[TBL] [Abstract][Full Text] [Related]
9. Fatigue in patients with cancer receiving interferon alpha.
Dean GE; Spears L; Ferrell BR; Quan WD; Groshon S; Mitchell MS
Cancer Pract; 1995; 3(3):164-72. PubMed ID: 7599673
[TBL] [Abstract][Full Text] [Related]
10. High-dose interleukin-2 in patients with metastatic melanoma whose disease progressed after biochemotherapy.
Buzaid AC; Schmerling RA; Vieira Guedes RA; de Freitas D; William WN
Melanoma Res; 2011 Aug; 21(4):370-5. PubMed ID: 21558968
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
Minor DR; Moore D; Kim C; Kashani-Sabet M; Venna SS; Wang W; Boasberg P; O'Day S
Oncologist; 2009 Oct; 14(10):995-1002. PubMed ID: 19776094
[TBL] [Abstract][Full Text] [Related]
12. Differences in fatigue by treatment methods in women with breast cancer.
Woo B; Dibble SL; Piper BF; Keating SB; Weiss MC
Oncol Nurs Forum; 1998 Jun; 25(5):915-20. PubMed ID: 9644708
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival in metastatic melanoma patients treated with sequential biochemotherapy: report of a Phase II study.
Neri B; Vannozzi L; Fulignati C; Pantaleo P; Pantalone D; Paoletti C; Perfetto F; Turrini M; Mazzanti R
Cancer Invest; 2006; 24(5):474-8. PubMed ID: 16939954
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of bortezomib in the treatment of metastatic malignant melanoma.
Markovic SN; Geyer SM; Dawkins F; Sharfman W; Albertini M; Maples W; Fracasso PM; Fitch T; Lorusso P; Adjei AA; Erlichman C
Cancer; 2005 Jun; 103(12):2584-9. PubMed ID: 15887220
[TBL] [Abstract][Full Text] [Related]
15. Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.
Lewis KD; Robinson WA; McCarter M; Pearlman N; O'Day SJ; Anderson C; Amatruda TT; Baron A; Zeng C; Becker M; Dollarhide S; Matijevich K; Gonzalez R
J Clin Oncol; 2006 Jul; 24(19):3157-63. PubMed ID: 16809738
[TBL] [Abstract][Full Text] [Related]
16. Fatigue, pain, and functional status during outpatient chemotherapy.
Siefert ML
Oncol Nurs Forum; 2010 Mar; 37(2):E114-23. PubMed ID: 20189910
[TBL] [Abstract][Full Text] [Related]
17. The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer: a multicenter study.
So WK; Marsh G; Ling WM; Leung FY; Lo JC; Yeung M; Li GK
Oncol Nurs Forum; 2009 Jul; 36(4):E205-14. PubMed ID: 19581224
[TBL] [Abstract][Full Text] [Related]
18. Fatigue and depression in patients with lymphoma undergoing autologous peripheral blood stem cell transplantation.
El-Banna MM; Berger AM; Farr L; Foxall MJ; Friesth B; Schreiner E
Oncol Nurs Forum; 2004 Sep; 31(5):937-44. PubMed ID: 15378094
[TBL] [Abstract][Full Text] [Related]
19. Level of fatigue in women receiving dose-dense versus standard chemotherapy for breast cancer: a pilot study.
Sura W; Murphy SO; Gonzales I
Oncol Nurs Forum; 2006 Sep; 33(5):1015-21. PubMed ID: 16955128
[TBL] [Abstract][Full Text] [Related]
20. Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.
Bedikian AY; Johnson MM; Warneke CL; McIntyre S; Papadopoulos N; Hwu WJ; Kim K; Hwu P
J Immunotoxicol; 2008 Apr; 5(2):201-7. PubMed ID: 18569391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
